Abstract | PURPOSE: A study using monoclonal antibody ProstaScint was conducted to determine the role of radioscintigraphy for evaluation of patients with adenocarcinoma of the prostate. Previous evaluations determining sensitivity and toxicity for this agent were conducted in a multicenter study. MATERIALS AND METHODS:
ProstaScint scans were used for preoperative staging in patients presumed to be candidates for total prostatectomy and a subsequent study was performed for the detection and localization of recurrent prostate cancer following definitive therapy. RESULTS: CONCLUSIONS:
|
Authors | J H Texter Jr, C E Neal |
Journal | The Journal of urology
(J Urol)
Vol. 160
Issue 6 Pt 2
Pg. 2393-5
(Dec 1998)
ISSN: 0022-5347 [Print] United States |
PMID | 9817390
(Publication Type: Clinical Trial, Journal Article)
|
Chemical References |
- Antibodies, Monoclonal
- Capromab Pendetide
|
Topics |
- Adenocarcinoma
(diagnostic imaging, pathology)
- Antibodies, Monoclonal
- Humans
- Male
- Neoplasm Recurrence, Local
(diagnostic imaging)
- Neoplasm Staging
- Postoperative Care
- Preoperative Care
- Prostatic Neoplasms
(diagnostic imaging, pathology)
- Radionuclide Imaging
|